232 related articles for article (PubMed ID: 14872002)
1. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa.
Wozniak DJ; Keyser R
Chest; 2004 Feb; 125(2 Suppl):62S-69S; quiz 69S. PubMed ID: 14872002
[TBL] [Abstract][Full Text] [Related]
2. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections.
Kobayashi H
Treat Respir Med; 2005; 4(4):241-53. PubMed ID: 16086598
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effect of macrolide antibiotics on biofilm formation by Pseudomonas aeruginosa].
Kondoh K; Hashiba M
Nihon Jibiinkoka Gakkai Kaiho; 1998 Jan; 101(1):25-36. PubMed ID: 9493436
[TBL] [Abstract][Full Text] [Related]
4. Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors.
Tateda K; Standiford TJ; Pechere JC; Yamaguchi K
Curr Pharm Des; 2004; 10(25):3055-65. PubMed ID: 15544497
[TBL] [Abstract][Full Text] [Related]
5. In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation.
Ichimiya T; Yamasaki T; Nasu M
J Antimicrob Chemother; 1994 Sep; 34(3):331-41. PubMed ID: 7829408
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors.
Alhajlan M; Alhariri M; Omri A
Antimicrob Agents Chemother; 2013 Jun; 57(6):2694-704. PubMed ID: 23545534
[TBL] [Abstract][Full Text] [Related]
7. Effect of subinhibitory concentration of piperacillin/tazobactam on Pseudomonas aeruginosa.
Fonseca AP; Extremina C; Fonseca AF; Sousa JC
J Med Microbiol; 2004 Sep; 53(Pt 9):903-910. PubMed ID: 15314198
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic characterization of multidrug-resistant Pseudomonas aeruginosa strains isolated from pediatric patients associated to biofilm formation.
Ochoa SA; Cruz-Córdova A; Rodea GE; Cázares-Domínguez V; Escalona G; Arellano-Galindo J; Hernández-Castro R; Reyes-López A; Xicohtencatl-Cortes J
Microbiol Res; 2015 Mar; 172():68-78. PubMed ID: 25530579
[TBL] [Abstract][Full Text] [Related]
9. Ginseng aqueous extract attenuates the production of virulence factors, stimulates twitching and adhesion, and eradicates biofilms of Pseudomonas aeruginosa.
Alipour M; Omri A; Suntres ZE
Can J Physiol Pharmacol; 2011 Jun; 89(6):419-27. PubMed ID: 21815782
[TBL] [Abstract][Full Text] [Related]
10. Sub-minimum inhibitory concentrations of ceftazidime inhibit Pseudomonas aeruginosa biofilm formation.
Otani S; Hiramatsu K; Hashinaga K; Komiya K; Umeki K; Kishi K; Kadota JI
J Infect Chemother; 2018 Jun; 24(6):428-433. PubMed ID: 29449129
[TBL] [Abstract][Full Text] [Related]
11. Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms.
Alkawash MA; Soothill JS; Schiller NL
APMIS; 2006 Feb; 114(2):131-8. PubMed ID: 16519750
[TBL] [Abstract][Full Text] [Related]
12. Extracellular ATP inhibits twitching motility-mediated biofilm expansion by Pseudomonas aeruginosa.
Nolan LM; Cavaliere R; Turnbull L; Whitchurch CB
BMC Microbiol; 2015 Mar; 15():55. PubMed ID: 25879216
[TBL] [Abstract][Full Text] [Related]
13. [Effect of macrolides on biofilm of mucoid Pseudomonas aeruginosa].
Chai D; Wang R; Pei F
Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(15):934-6. PubMed ID: 11702671
[TBL] [Abstract][Full Text] [Related]
14. Subinhibitory concentrations of phenyl lactic acid interfere with the expression of virulence factors in Staphylococcus aureus and Pseudomonas aeruginosa clinical strains.
Chifiriuc MC; Diţu LM; Banu O; Bleotu C; Drăcea O; Bucur M; Larion C; Israil AM; Lazăr V
Roum Arch Microbiol Immunol; 2009; 68(1):27-33. PubMed ID: 19507624
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B
Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
[TBL] [Abstract][Full Text] [Related]
16. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function.
Hentzer M; Teitzel GM; Balzer GJ; Heydorn A; Molin S; Givskov M; Parsek MR
J Bacteriol; 2001 Sep; 183(18):5395-401. PubMed ID: 11514525
[TBL] [Abstract][Full Text] [Related]
17. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
Murray TS; Egan M; Kazmierczak BI
Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
[TBL] [Abstract][Full Text] [Related]
19. Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection.
Heidari H; Hadadi M; Sedigh Ebrahim-Saraie H; Mirzaei A; Taji A; Hosseini SR; Motamedifar M
J Fr Ophtalmol; 2018 Nov; 41(9):823-829. PubMed ID: 30292385
[TBL] [Abstract][Full Text] [Related]
20. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.
Riera E; Macià MD; Mena A; Mulet X; Pérez JL; Ge Y; Oliver A
J Antimicrob Chemother; 2010 Jul; 65(7):1399-404. PubMed ID: 20435779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
